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Abstract
Background: The advent of urine testing for Chlamydia trachomatis has raised the possibility of
large-scale screening for this sexually transmitted infection, which is now the most common in the
United Kingdom. The purpose of this study was to investigate the effect of an invitation to be
screened for chlamydia and of receiving a negative result on levels of anxiety, depression and self-
esteem.
Methods: 19,773 men and women aged 16 to 39 years, selected at random from 27 general
practices in two large city areas (Bristol and Birmingham) were invited by post to send home-
collected urine samples or vulvo-vaginal swabs for chlamydia testing. Questionnaires enquiring
about anxiety, depression and self-esteem were sent to random samples of those offered screening:
one month before the dispatch of invitations; when participants returned samples; and after
receiving a negative result.
Results: Home screening was associated with an overall reduction in anxiety scores. An invitation
to participate did not increase anxiety levels. Anxiety scores in men were lower after receiving the
invitation than at baseline. Amongst women anxiety was reduced after receipt of negative test
results. Neither depression nor self-esteem scores were affected by screening.
Conclusion: Postal screening for chlamydia does not appear to have a negative impact on overall
psychological well-being and can lead to a decrease in anxiety levels among respondents. There is,
however, a clear difference between men and women in when this reduction occurs.
Published: 25 April 2006
BMC Public Health2006, 6:106 doi:10.1186/1471-2458-6-106
Received: 20 October 2005
Accepted: 25 April 2006
This article is available from: http://www.biomedcentral.com/1471-2458/6/106
© 2006Campbell et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 8
(page number not for citation purposes)
BMC Public Health 2006, 6:106 http://www.biomedcentral.com/1471-2458/6/106Background
Health care is usually provided when an individual
patient seeks help. In contrast population-screening pro-
grammes seek to identify disease in groups of people who
have not sought care. While the overall aim of screening is
to improve population health by reducing preventable
morbidity and mortality, not everyone in the population
screened will benefit as individuals. In particular, screen-
ing programmes therefore have the potential to harm by
causing unnecessary distress to those who do not have the
condition, or by falsely reassuring those who have the
condition but who have negative screening tests. Those
who test positive and do have the condition have to cope
with an unexpected and unsought diagnosis. The costs of
screening programmes are usually evaluated in economic
terms, but there is increasing recognition of the need to
assess the psychological costs for those participating [1,2].
While other conditions such as human papilloma virus
infections are considered to be more prevalent, Chlamydia
trachomatis is now the most commonly reported sexually
transmitted infection in the United Kingdom [3]. Oppor-
tunistic screening of sexually active women and men
under 25 years of age is being introduced in England with
the aim of reducing the prevalence of chlamydia and of
severe reproductive tract morbidity in women [4]. Popu-
lation screening for chlamydia has become more feasible
in recent years because of nucleic acid amplification tests
that can be carried out reliably on non-invasively col-
lected specimens such as urine and vulval swabs. Testing
kits can be sent to large numbers of people who can col-
lect specimens in the privacy of their own home [5,6].
Given its innovatory nature, there is as yet no substantial
evidence about the psychological impact of receiving an
invitation for chlamydia screening and of taking part in
home testing. Qualitative research has shown that women
find accessing specialist sexual health services and being
diagnosed with chlamydia stigmatising [7,8] and distress-
ing [9], so receiving an unsolicited invitation to be tested
for a sexually transmitted infection may also evoke feel-
ings of stigma and adversely impact on the recipient's
sense of self worth. Research has also revealed that being
tested positive for chlamydia introduces concern about
the potential impact of such a diagnosis on relationships
[8] and worries about future fertility [8,9]. Such anxieties
could also be triggered by an invitation to be screened for
chlamydia. Receiving an invitation to attend for breast
screening has been reported to provoke anxiety in the
recipients [10,11].
The Chlamydia Screening Studies (ClaSS) project was a
multidisciplinary series of studies designed to investigate
epidemiological, laboratory, economic, and social and
psychological aspects of systematic home-based screening
for chlamydia [12]. The purpose of the study reported
here was to assess whether home-based screening for
chlamydia had an adverse effect on levels of anxiety,
depression and self-esteem in those screened and whether
anxiety scores returned to pre-screening levels in those
receiving negative test results.
Methods
The rationale and methods of the ClaSS project have been
described previously [12]. In brief, 19,773 men and
women aged 16 to 39 years registered with one of 27 gen-
eral practices in the Bristol and Birmingham areas were
selected at random. After an interim analysis in the first
four practices showed chlamydia prevalence in the older
age group to be very low [12], invitations were subse-
quently only sent to those aged 16–25 years. They each
received an invitation letter from their general practitioner
followed by a study pack with information and instruc-
tions on how to provide a home-collected urine and/or
vulval swab specimen to be tested for C. trachomatis [12].
Study packs were sent to individuals in each practice in
turn between February 2001 and July 2002. Participants
with negative test results were informed by letter, and
those with positive results were sent an appointment to
see a practice nurse at their general practice.
Study population
As described above, the potential sampling frame was all
individuals aged 16–39 years in 27 randomly selected
practices. We excluded individuals selected from the first
two general practices in case publicity surrounding the
launch of the ClaSS project influenced the pre-screening
measurements. We planned to measure responses in a
cohort of 1000 individuals randomly sampled from all
those invited to be screened, stratified by age group (16–
25 and 26–39 years), sex and practice. Data were intended
to be collected at three time points: one month before the
invitation was posted (baseline); at the time of screening;
and after receipt of a negative test result. Because of low
response rates to the screening study overall, accrual of the
cohort was slow and, in the last 12 study practices, we
decided instead to select independent cross-sectional ran-
dom samples of individuals at each of the three time
points, stratified by sex and practice (all individuals now
being 16–25 years old).
As part of the ClaSS project all those with a positive test
result and a matched sample of people who tested nega-
tive were invited to take part in a case-control study. We
did not send the final questionnaire for this study to peo-
ple selected for the case-control study as their experiences
would not have been typical of people participating in a
population-based chlamydia screening programme.
Completion of the questionnaire before screening was
considered implied consent. Thereafter, all those wishingPage 2 of 8
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and sign a consent form. The South and West Multi-Cen-
tre Research Ethics Committee approved the ClaSS
project.
Outcome measures
We used the Hospital Anxiety and Depression Scale
(HAD) [13], which has been used in a number of studies
evaluating the impact of screening, as our main outcome
measure. This comprises seven item subscales for anxiety
and depression, each with a total score ranging from 0 to
21. We also used the Rosenburg Self Esteem Scale [14] as
a further measure of the possible stigmatising effects of
screening for a sexually transmitted infection. This com-
prises ten items with a total score range of 10 to 40.
Sample size
Using data from a study of anxiety and breast screening, a
standard deviation of 2.4 for paired differences between
anxiety scores recorded at baseline and receipt of an invi-
tation to be screened was anticipated for those in the
cohort study (K. Vedhara, personal communication). For
a mean difference in anxiety scores of 1, a sample size of
355 would result in a 95% confidence interval of 0.75 to
1.25 (that is a margin of error of 0.25 points on the anxi-
ety score), taking into account the benefits of analysing
within-person differences. This was considered to be an
adequate level of precision. To achieve this level of
response at all three time points allowing for non-
response and attrition, a random sample of 1000 was ini-
tially drawn. For the cross-sectional samples we estimated
that 130 participants at each time point would yield a
margin of error of 0.3 standard deviations for a compari-
son between anxiety scores at any two time points after
correcting for multiple testing.
Statistical analysis
Analyses were undertaken using Stata [15]. The primary
analysis included individuals from both the cohort and
the cross-sectional samples. Mean scores for anxiety,
depression and self-esteem at the three time points were
compared using generalised estimating equations [16] to
allow for within-individual variation in the cohort. In
addition, practice was incorporated as a fixed effect and
practice-specific sampling fractions were allowed for
using appropriate weights in the regression analyses.
Results
Overall, 687 people from 13 practices were invited to par-
ticipate in the cohort sample and a total of 1533 people
from 12 practices were invited to participate in the three
cross-sectional study samples. Questionnaire reply rates
to the cohort and cross-sectional approaches were very
similar (Table 1). Forty-two per cent of individuals
responded to the baseline questionnaire. After excluding
individuals selected to be in the case-control study and
those with positive results, response rates at each time
point were 60% or more.
Sixty percent of the sample was female, reflecting a higher
response rate amongst women (Table 2). Only 13% of the
sample was aged 26 to 39 years, reflecting the age distribu-
Table 1: Numbers in the study and reply and response rate, for each time period, by sampling design
Time Period
Before invitation At invitation After receipt of negative result
Number sent Number returned (%) Number sent Number returned (%) Number sent Number returned (%)
Questionnaire reply 
ratesa
Cohort 687 297 (43%) 680 177 (26%) 172 126 (73%)
Cross-sectional 624 250 (40%) 763 241 (32%) 146 101 (69%)
All 1311 547 (42%) 1443 418 (29%) 318 227 (71%)
Analysis response 
ratesb
Cohort 186 113 (61%) 186 168 (90%) 172 126 (73%)
Cross-sectional 175 105 (60%) 244 229 (94%) 146 101 (69%)
All 361 218 (60%) 430 397 (92%) 318 227 (71%)
a. Denominator: all individuals to whom questionnaires were posted.
Numerator: all those who replied regardless of their chlamydia test result and regardless of their inclusion in the case-control study.
b. Denominator: all individuals with a negative test result and not included in the case-control study.
Numerator: of these individuals, those who responded.Page 3 of 8
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section. From Table 2, therefore, overall the samples are
such that males were under-represented.
Moreover, from previous detailed research on the repre-
sentativeness of those responding to the invitation to be
screened (the time point labelled "At invitation" in this
paper), it is clear that the non-response was higher for
those practices with scores indicating higher levels of dep-
rivation [17,18]. The odds ratio (OR) of response was
0.88 (95% confidence interval (CI) 0.80, 0.96; p = 0.004)
for a 10-point increase in deprivation score, adjusting for
age, sex and ethnicity, and taking account of sampling
probability and clustering by practice [17,18]. On the
other hand, after making such adjustments (especially for
deprivation) there was no evidence of non-representative-
ness for ethnicity itself (OR = 0.98, 95% CI 0.92, 1.05; p =
0.71) [17,18]. This time point is that with the lowest over-
all response rate (29% from Table 1), and hence, if any-
thing, the patterns of differential response are likely to be
at their most pronounced.
The descriptive statistics for the three psychological meas-
ures according to age and sex are presented in Table 3.
These descriptive statistics were very similar whether from
cross sectional or cohort data. For example, the mean anx-
iety, depression and self esteem scores for women aged
16–25 in the cohort were 8.14, 3.63 and 7.46 respectively.
The corresponding mean scores in the cross sectional data
were 7.87, 3.45 and 7.56. The focus will therefore now be
restricted to the analyses of all study individuals. For all
three measures the scores for the majority of individuals
were lower than conventional thresholds for clinical inter-
vention, although there was considerable variation and
some individuals did have levels that would cause con-
cern. In general anxiety levels were higher amongst
women but there do not appear to be differences across
the age groups. Depression scores were higher in the older
age group and in women. Self-esteem was lower in the
younger age groups but only amongst women.
Table 4 shows, for all study individuals, the results of sta-
tistical models investigating changes in the three psycho-
logical measures over time, with full adjustment for the
sampling design as well as the potential confounding
effects of age and sex. In addition to the overall effects
across time, the models also investigated differential time
patterns according to sex and age group by considering
relevant interaction terms.
There was a clear decrease in anxiety levels across time
(overall p = 0.0049), and strong evidence that this pattern
was different for men and women (p for interaction
0.012). In particular, Figure 1 shows that the decline in
men's anxiety levels occurred when they submitted their
test sample, whereas for women anxiety levels only
Table 2: Number and percentages of respondents according to age and sex for each time period
Sex Age group Before invitation At invitation After receipt of negative 
result
Total
Years N (%) N (%) N (%) N (%)
Male 16–25 64 (29) 146 (37) 76 (34) 286 (34)
26–39 13 (6) 21 (5) 18 (8) 52 (6)
All 77 (35) 167 (42) 94 (41) 338 (40)
Female 16–25 123 (56) 209 (53) 113 (50) 445 (53)
26–39 18 (8) 21 (5) 20 (9) 59 (7)
All 141 (65) 230 (58) 133 (59) 504 (60)
Total 218 (100) 397 (100) 227 (100) 842 (100)
Table 3: Anxiety, depression and self-esteem scores according to sex and age for all three time periods
Sex Age group Anxiety Depression Self-esteem
Years Mean (SD) Mean (SD) Mean (SD)
Male 16–25 6.52 (3.60) 3.01 (2.8) 8.57 (1.97)
26–39 6.27 (3.38) 4.12 (3.6) 8.39 (2.34)
Female 16–25 8.14 (3.89) 3.63 (3.2) 7.46 (2.72)
26–39 8.28 (3.63) 4.42 (3.2) 8.47 (2.21)
All All 7.49 (3.82) 3.50 (3.1) 7.96 (2.48)Page 4 of 8
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is there any suggestion of an increase in anxiety as a result
of receiving the invitation, at least amongst those
responding to questionnaires. There were no clear pat-
terns across the three time points for measures of depres-
sion and self-esteem. There is a slight suggestion of a
narrowing of the different depression scores between men
and women at invitation, but the evidence for this is mar-
ginal and there is no clear interpretation for this finding.
Discussion
Most people who participate in screening programmes
will receive a negative test result. From the analyses pre-
sented here, population screening for chlamydia does not
seem to have a deleterious impact on the psychological
well-being of those tested and found to be negative.
Indeed the findings suggest that being tested for chlamy-
dia in this way has the effect of relieving rather than creat-
ing anxiety.
Comparisons with other studies
The findings from our study are broadly consistent with
those observed for other screening programmes, which
suggest that these individuals are unlikely to suffer pro-
found or long-lasting emotional effects as a result of par-
ticipating, and that the experience may even have a
positive effect on their well-being. For example, a recent
questionnaire-based survey of a random sample of men
and women aged 15 to 29 who responded to an invitation
for be screened for chlamydia by means of a home based
urine sample in the Netherlands, found that 42 % felt
relief at receiving a negative result and that only a small
minority of those receiving a negative result remained
anxious [6]. For Scottish women who participated in a
series of focus groups, the wait for test results from cervical
cancer screening was deemed to be an anxious period, but
this was soon replaced by a sense of relief upon receipt of
a normal result [19]. Sutton et al[20] assessed the psychi-
atric morbidity of women with negative results before and
after breast cancer screening. From this study there was lit-
tle evidence to suggest that breast cancer screening per se
causes psychological morbidity. A number of studies have
reported no change in anxiety and depression scores
before and after screening [10,20,21], and one found a
lowering of scores between baseline and screening [22]. A
randomised trial of an educational intervention for
women under surveillance for mild dyskaryosis detected
during routine cervical screening in the UK found that the
raised anxiety amongst these women was difficult to
reduce [23].
Positive effects of screening of those tested negative have
also been shown in other studies. Reelick et al [24] con-
ducted a controlled before-after study of women partici-
pating in a cervical cancer-screening programme in the
Netherlands and found that negative results were associ-
ated with a diminution in the scores for psychiatric distur-
bance at follow-up; hence screening offered a
psychological benefit for some participants. Women in
Bakker et al's study [25] reported that breast screening had
had relatively little impact on social or physical aspects of
their lives. Indeed, screening had a positive effect on cer-
tain emotional issues for at least 50% of them, including
inducing feelings of reassurance that they did not have
cancer, and enhancing their sense of well-being and their
hopes for the future. Furthermore, Scaf-Klomp et al [26]
and Gram et al [27] in their controlled studies of the psy-
chological side effects of breast cancer screening reported
less psychological morbidity post screening in those who
received a negative result compared with a population
sample who had not been invited to be screened. Con-
versely, when Stoate [28] explored whether screening can
Table 4: Differences between mean anxiety, depression and self-esteem scores over the three time points together with p values for 
overall differences across time and for interactions between time point and age and sex
Score Time Point Difference 
between means
(95% CI)1 Difference between 
time points
P values Interaction 
with age band
Interaction with sex
Anxiety 0.0049 0.99 0.012
Before invitation 0
At invitation -0.66 (-1.23, -0.09)
Negative result received -0.99 (-1.60, -0.38)
Depression 0.25 0.41 0.041
Before invitation 0
At invitation -0.47 (-1.09, 0.15)
Negative result received -0.26 (-0.91, 0.39)
Self-esteem 0.26 0.27 0.98
Before invitation 0
At invitation 0.12 (-0.26, 0.50)
Negative result received -0.13 (-0.57, 0.31)
1 From model with no interaction terms. Adjusted for age band, sex, practice and clustering effects, and weighted to account for sampling 
probability.Page 5 of 8
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those invited to a coronary heart disease screening clinic,
he found that levels of distress, as assessed by the General
Health Questionnaire, were significantly higher after than
before cardiovascular risk screening in those who received
negative or low risk results, suggesting that there is a risk
of causing distress when screening healthy adults.
Study strengths and limitations
The findings reported here are based on a large, commu-
nity-based chlamydia screening study that included both
men and women aged 16 to 39. Although the question-
naire reply rates were not high, the response rates amongst
those included in the analysis ranged from 60% to 92%
across the three time points at which data were collected.
This combined with the fact that the three psychometric
measures used are well established, and have been the
subject of rigorous psychometric testing, means that we
can be confident that findings are reliable. These analyses
do, however, also have a number of limitations. Low reply
rates in the cohort study promoted a change of sampling
method, and although we were able to fully account for
the use of these two different sampling designs in the
analysis, it remains the case that we were only able to ana-
lyse the psychometric data for those who responded and
it is possible that the non responders had a different pro-
file. We relied on three psychological measures that have
commonly been used in this type of evaluation but it is
possible that ClaSS had other deleterious effects not
reflected in these measures. Moreover, our analyses reflect
average effects of chlamydia screening and it is only pos-
sible to look in detail at the variation in peoples' experi-
ences qualitatively [29].
Predicted Mean Score for Three Psychological Measures According to Age, Sex and Time PointaFigure 1
Predicted Mean Score for Three Psychological Measures According to Age, Sex and Time Pointa.
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When screening for sexually transmitted infections there
is always the potential for increasing psychological mor-
bidity regardless of whether there are overall health bene-
fits of screening. These findings, however, suggest that
postal screening for Chlamydia trachomatis does not have a
measurable adverse impact on psychological well-being at
the population level. Indeed, individuals who took up an
invitation and tested negative for chlamydia experienced
a reduction in anxiety. For men this reduction occurred
when they sent off a urine sample for testing; for women
it came with the receipt of a negative test result. The policy
implications of these findings are that unsolicited chlamy-
dia test kits can be sent by post to population groups at
risk, as part of a screening programme, because this does
not appear to harm the vast majority of those screened
who do not have the infection.
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